✨ Ask AkshayaAI anything about this stock — instant AI answers. Try the AI assistant →
AkshayaAIStocks › MRK

MRK — Merck & Co Inc

AI Signal & Stock Analysis · Very Strong ↑

As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for MRK is Very Strong ↑; the stock is at $135.85 (+0.22% today); neutral (RSI 68); technical trend is Raise; news sentiment is nan.

Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.

Key metrics

AI signal (Strength)Very Strong ↑
Price$135.85
Change today+0.22%
RSI (14)68.50
Relative volume0.35
Composite (RMTPGV) score🔒 members
Market cap$335.2B
Forward P/E14.21
52-week high0.0% away
52-week low+75.0% above
Technical trendRAISE-2024-01-26
News sentimentNan
SectorHealthcare-Pharma
Next earnings8/4/2026 8:30:00 AM

What's driving the signal

🔒 AkshayaAI factor scores — Momentum, Technical, Performance, Growth, Volatility and the composite RMTPGV score are members-only. Sign in free to see the full breakdown →
Ask a follow-up or get live data on MRK → open the AI assistant

Frequently asked about MRK

What is AkshayaAI's signal for MRK today?

As of Aug 14 2026, 1:04 PM, AkshayaAI assigns MRK (Merck & Co Inc) a Very Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.

Is MRK overbought or oversold right now?

MRK's RSI is neutral (RSI 68). A reading above 70 is typically considered overbought and below 30 oversold.

Where is MRK in its 52-week range?

MRK is trading about 0% below its 52-week high and 75% above its 52-week low as of Aug 14 2026, 1:04 PM.

When is MRK's next earnings date?

MRK's next earnings date is 8/4/2026 8:30:00 AM.

What sector is MRK in?

MRK is classified under Healthcare-Pharma in AkshayaAI's taxonomy.

AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.

🤖

Ask AkshayaAI about MRK

Instant, data-backed answers — free to try.